Medical Microbiology

Höfundur Anil K. Sharma, Girish Kumar Gupta, Mukesh Yadav

Útgefandi De Gruyter

Snið ePub

Print ISBN 9783110517644

Útgáfa 1

Útgáfuár 2022

11.790 kr.

Description

Efnisyfirlit

  • About the editors
  • List of contributing authors
  • Pooja Mittal, Ramit Kapoor, Rupesh K. Gautam Chapter 1 Introduction of microbiology
  • 1.1 Introduction
  • 1.2 Microbial classification
  • 1.2.1 Bacteria
  • 1.2.2 Archaea
  • 1.2.3 Fungi
  • 1.2.4 Protozoa (singular – protozoan)
  • 1.2.5 Algae
  • 1.2.6 Virus
  • 1.2.7 Multicellular animal parasites
  • 1.3 Bacterial morphology and cytology
  • 1.3.1 Structural components of bacterial cell/prokaryotic cell
  • 1.4 Bacterial/microbial culture
  • 1.4.1 Broth cultures
  • 1.4.2 Agar plate culture
  • 1.4.3 Stab culture
  • Namrata Malik Chapter 2 Bacteriology
  • 2.1 Bacterial morphology and structures: metabolism and growth
  • 2.1.1 Bacterial morphology
  • 2.1.2 Bacterial growth
  • 2.1.3 Bacterial growth curve
  • 2.1.4 Calculations of growth
  • 2.2 Bacterial heredity and variation
  • 2.2.1 Heredity and variation
  • 2.2.2 Genotypic and phenotypic variation
  • 2.3 Bacterial infection and pathogenesis
  • 2.3.1 Pathogenesis
  •  2.3.1.1 Types of bacterial pathogens
  •  2.3.1.2 Koch’s postulates
  •  2.3.1.3 Transmission of infection
  • 2.4 Immune responses to bacterial infections
  • 2.4.1 Immune mechanisms
  • 2.5 Chemotherapy: control of bacterial diseases and diagnosis
  • 2.5.1 Chemotherapy
  • 2.6 Systemic bacteriology and bacterial diseases
  • 2.6.1 Systemic bacteriology
  • 2.6.2 Arthropod-borne disease
  • 2.6.3 Direct contact disease
  • 2.6.4 Foodborne and waterborne disease
  • 2.6.5 Sepsis and septic shock
  • 2.6.6 Dental infections
  • Malay Kumar Sannigrahi, Deepika Chapter 3 Virology
  • 3.1 Introduction
  • 3.2 Viral classification, structure and multiplication
  • 3.3 Heredity and variation in viruses
  • 3.3.1 Mutations
  • 3.3.2 Recombination
  • 3.4 Immune response to viral infections
  • 3.5 Control of viral diseases
  • 3.6 Laboratory diagnosis of virus infection and antivirus therapy
  • 3.7 Respiratory infective myxoviruses
  • 3.7.1 Type-I myxovirus
  • 3.7.2 Type-II myxovirus
  • 3.7.3 Gastrointestinal virus and rhinovirus
  • 3.7.4 Hepatitis A virus
  • 3.7.5 Hepatitis B virus
  • 3.7.6 Hepatitis C virus
  • 3.7.7 Hepatitis D virus
  • 3.7.8 Hepatitis E virus
  • 3.7.9 The GB hepatitis viruses
  • 3.8 Arthropod-borne and rodent-borne viral disease
  • 3.8.1 Togaviruses
  • 3.8.2 Bunyaviridae
  • 3.8.3 Flaviviruses
  • 3.9 Retrovirus and human immunodeficiency virus
  • 3.9.1 Life cycle
  • 3.9.2 Pathogenesis
  • 3.9.3 Human immunodeficiency virus (HIV)
  • 3.10 Human herpesvirus (HHV)
  • 3.10.1 Human herpesvirus 1 (HHV1)
  • 3.10.2 Human herpesvirus 2 (HHV2)
  • 3.10.3 Human herpesvirus 3 (HHV3)
  • 3.10.4 Human herpesvirus 4 (HHV4, Epstein–Barr virus)
  • 3.10.5 Human herpesvirus 5 (HHV5)
  • 3.10.6 Human herpesvirus 6
  • 3.10.7 Human herpesvirus 7
  • 3.10.8 Human herpesvirus 8
  • 3.10.9 Multiplication
  • 3.10.10 Detection
  • 3.10.11 Control and treatment
  • 3.11 Human cancer virus
  • 3.11.1 Human T-cell leukemia virus (HTLV-1)
  • 3.11.2 Human papillomavirus
  • 3.11.3 Epstein–Barr virus (EBV)
  • 3.11.4 Kaposi’s sarcoma-associated herpesvirus (KSHV)
  • 3.12 Rabies virus
  • 3.12.1 Life cycle
  • 3.12.2 Pathogenesis
  • 3.12.3 Detection
  • 3.12.4 Control and treatment
  • 3.13 Coronavirus
  • 3.13.1 Life cycle
  • 3.13.2 Pathogenesis
  • 3.13.3 Detection
  • 3.13.4 Control and treatment
  • 3.14 Rubella virus
  • 3.14.1 Life cycle
  • 3.14.2 Pathogenesis
  • 3.14.3 Detection
  • 3.14.4 Control and treatment
  • 3.15 Prion
  • 3.15.1 Life cycle
  • 3.15.2 Types
  • 3.16 Conclusion
  • Younis Ahmad Hajam, Rahul Datta, Sonika, Ajay Sharma, Rajesh Kumar, Abhinay Thakur, Anil Kumar Sharma Chapter 4 Parasitology
  • 4.1 Pathogenesis of parasitic diseases
  • 4.2 Laboratory diagnosis of parasitic diseases
  • 4.2.1 Microscopy
  • 4.2.2 Serologic assays
  • 4.2.3 Falcon assay screening test-ELISA (FAST-ELISA)
  • 4.2.4 Dot-ELISA
  • 4.2.5 Rapid antigen detection system (RDTS)
  • 4.2.6 Molecular approaches
  • 4.3 Intestinal and urogenital protozoa
  • 4.3.1 Entamoeba histolytica
  • 4.3.2 Giardia lamblia
  • 4.3.3 Cryptosporidium hominis
  • 4.3.4 Trichomonas vaginalis
  • 4.4 Antiparasitic agents
  • 4.4.1 Antiprotozoal agents
  • 4.5 Blood and tissue protozoans of human
  • 4.5.1 Trypanosoma
  • 4.5.2 Leishmania
  • 4.5.3 Plasmodium
  • 4.6 Helminthes
  • 4.6.1 General concept for the basis of classification
  • 4.6.2 Classification
  • 4.6.3 Nematodes (roundworms)
  • 4.6.4 Trematoda
  • 4.6.5 Cestoda
  • 4.7 Arthropoda
  • 4.7.1 Vector-borne diseases
  • 4.7.2 Sandfly-borne diseases
  • 4.7.3 Tick-borne diseases
  • 4.7.4 Babesiosis
  • 4.7.5 Anaplasmosis
  • 4.7.6 Southern tick-associated rash illness (STARI)
  • Amit Kumar Singh Chapter 5 Mycology
  • 5.1 Introduction
  • 5.2 Mycosis
  • 5.3 Classification of mycosis
  • 5.3.1 Superficial
  • 5.3.2 Subcutaneous mycoses
  • 5.3.3 Systemic or deep tissue mycoses
  • 5.4 Laboratory diagnosis of fungal diseases
  • 5.4.1 In vitro culture test
  • 5.4.2 Microscopic examination
  • 5.4.3 Serodiagnosis
  • 5.4.4 PCR detection method
  • 5.4.5 Sequencing-based detection
  • 5.4.6 MALDI analysis
  • 5.5 Dimorphism in the pathogenic fungi
  • 5.6 Histoplasmosis
  • 5.7 Blastomycosis
  • 5.8 Coccidioidomycosis
  • 5.9 Emmonsia disease
  • 5.10 Fungal and fungal-like infections of unusual or uncertain etiology
  • 5.10.1 Adiaspiromycosis
  • 5.10.2 Coccidioidomycosis
  • 5.10.3 Entomophthoromycosis
  • 5.10.4 Lacaziosis
  • 5.10.5 Rhinosporidiosis
  • 5.11 Mycotoxins and mycotoxicoses
  • 5.11.1 Aflatoxins
  • 5.11.2 Citrinin
  • 5.11.3 Cyclopiazonic acid
  • 5.11.4 Ergot alkaloids
  • 5.11.5 Fumonisins
  • 5.11.6 Ochratoxins
  • 5.11.7 Patulin
  • 5.11.8 Trichothecenes
  • 5.11.9 Zearalenone
  • 5.12 Antifungal agents
  • 5.12.1 Allylamines
  • 5.12.2 Azole antifungal drugs
  • 5.12.3 Griseofulvin antifungal drug
  • 5.12.4 Polyene antifungal drugs
  • 5.12.5 Echinocandins
  • 5.12.6 Flucytosine
  • Saloni Singh Chapter 6 Microbial assay techniques
  • 6.1 Microbiology
  • 6.1.1 Microbiological stains
  • 6.1.2 Stains
  • 6.2 Bacteriology
  • 6.3 Staining
  • 6.3.1 Types of staining
  • 6.3.2 Differential staining
  • 6.3.3 Special staining procedure
  • 6.3.4 Simple staining
  • 6.3.5 Biochemical assay
  • 6.4 Mycology
  • 6.4.1 Staining methods
  • 6.4.2 KOH staining
  • 6.4.3 Calcofluor white stain
  • 6.4.4 India ink staining
  • 6.5 Parasitology
  • 6.5.1 Assay of parasites
  • Anil Kumar, Shailja Sankhyan, Abhishek Walia, Chayanika Putatunda, Dharambir Kashyap, Ajay Sharma, Anil K Sharma Chapter 7 Antimicrobial resistance: medical science facing a daunting challenge
  • 7.1 Introduction
  • 7.2 Molecular cascade in antimicrobial resistance
  • 7.3 Biochemical aspects of antibiotic resistance
  • 7.3.1 Antibiotic inactivation
  • 7.3.2 Target modification
  • 7.3.3 Efflux pumps and decreased membrane permeability
  • 7.4 Antimicrobial susceptibility testing
  • 7.4.1 Disk diffusion/Kirby–Bauer method
  • 7.4.2 Agar well diffusion method
  • 7.4.3 Broth dilution method
  • 7.4.4 Agar dilution method
  • 7.4.5 E-test
  • 7.4.6 Future alternatives to AST
  • 7.5 Multidrug resistance
  • 7.5.1 Methicillin-resistant Staphylococcus aureus
  • 7.5.2 Vancomycin-resistant Enterococci
  • 7.5.3 Extensively drug-resistant TB
  • 7.5.4 Drug-resistant viruses
  • 7.6 Conclusions
  • Nazia Tarannum, Ranjit Hawaldar Chapter 8 Microbiology as an occupational hazard: risk and challenges
  • 8.1 Components of microbiological wastes: introduction
  • 8.2 Role of microbiology hazards in various occupations
  • 8.3 Occupational zoonotic diseases
  • 8.4 Legislation and safety policies
  • 8.5 Biosafety measures in microbiological laboratories
  • 8.5.1 Preplacement medical evaluations
  • 8.5.2 Vaccines
  • 8.5.3 Medical evaluations periodically
  • 8.5.4 Proper disposal of healthcare wastes
  • 8.6 Challenges faced by occupational hazard
  • 8.7 Conclusion
  • Preeti Kumari Sharma, Paavan Singhal Chapter 9 Medical waste management
  • 9.1 Introduction
  • 9.2 Definitions
  • 9.3 Type of medical waste
  • 9.4 Accompanying risks
  • 9.4.1 Channeling pathways
  • 9.5 Minimizing risks of medical wastes
  • 9.5.1 Infectious microorganisms associated with hospital medical waste
  • 9.6 Hazard group and containment level
  • 9.6.1 Hazard groups
  • 9.6.2 Levels of biohazard
  • 9.6.3 Laboratory biosafety level criteria
  • 9.6.4 Biosafety level 1
  • 9.6.5 Biosafety level 2
  • 9.6.6 Biosafety level 3
  • 9.6.7 Biosafety level 4
  • 9.7 Antiseptics and disinfectants
  • 9.7.1 Antiseptics
  • 9.7.2 Disinfectants
  • 9.7.3 Properties/characteristics of antiseptics and disinfectants
  • 9.7.4 Some of the commonly used antiseptics and disinfectants
  • 9.7.5 Glutaraldehyde
  • 9.8 Brief account of biomedical waste management
  • 9.8.1 Waste treatment management
  • 9.9 Education and training
  • Index
Show More

Additional information

Veldu vöru

Rafbók til eignar

Aðrar vörur

1
    1
    Karfan þín
    Africa 2.0
    Africa 2.0
    Veldu vöru:

    Rafbók til eignar

    1 X 4.590 kr. = 4.590 kr.